Human Immunodeficiency Virus Type 1 Vpr Impairs Dendritic Cell Maturation and T-Cell Activation: Implications for Viral Immune Escape
暂无分享,去创建一个
C. Rinaldo | Xiao-li Huang | B. Majumder | E. Schafer | V. Ayyavoo | M. L. Janket | J. Kan‐Mitchell | Keri L. Schaubert | Xiao-li Huang
[1] J. Andersson,et al. HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. , 2004, Blood.
[2] F. Belardelli,et al. Human Immunodeficiency Virus Type 1 gp120 Induces Abnormal Maturation and Functional Alterations of Dendritic Cells: a Novel Mechanism for AIDS Pathogenesis , 2004, Journal of Virology.
[3] M. Viora,et al. HIV‐1 Nef equips dendritic cells to reduce survival and function of CD8+ T cells: a mechanism of immune evasion , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] Christine Trumpfheller,et al. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[5] John P. Moore,et al. Blockade of Attachment and Fusion Receptors Inhibits HIV-1 Infection of Human Cervical Tissue , 2004, The Journal of experimental medicine.
[6] Qingsheng Li,et al. Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[7] Yoshiyuki Nagai,et al. Impaired Processing and Presentation of Cytotoxic-T-Lymphocyte (CTL) Epitopes Are Major Escape Mechanisms from CTL Immune Pressure in Human Immunodeficiency Virus Type 1 Infection , 2004, Journal of Virology.
[8] M. Hommel. On the dynamics of T‐cell activation in lymph nodes , 2004, Immunology and cell biology.
[9] P. Jolicoeur,et al. The AIDS-Like Disease of CD4C/Human Immunodeficiency Virus Transgenic Mice Is Associated with Accumulation of Immature CD11bHi Dendritic Cells , 2003, Journal of Virology.
[10] N. Teleshova,et al. Immunodeficiency virus exploitation of dendritic cells in the early steps of infection , 2003, Journal of leukocyte biology.
[11] Bali Pulendran,et al. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin , 2003, Nature.
[12] M. Stevenson,et al. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection , 2003, Nature.
[13] D. McDonald,et al. Recruitment of HIV and Its Receptors to Dendritic Cell-T Cell Junctions , 2003, Science.
[14] Özlem Türeci,et al. Cascades of transcriptional induction during dendritic cell maturation revealed by genome‐wide expression analysis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] I. Lossos,et al. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies , 2003, Leukemia.
[16] A. Glazyrin,et al. Analysis of in vitro immunization: generation of cytotoxic T-lymphocytes against allogeneic melanoma cells with tumor lysate-loaded or tumor RNA-transfected antigen-presenting cells , 2003, Cancer Immunology, Immunotherapy.
[17] S. Volpi,et al. HIV-1 Protein Vpr Suppresses IL-12 Production from Human Monocytes by Enhancing Glucocorticoid Action: Potential Implications of Vpr Coactivator Activity for the Innate and Cellular Immunity Deficits Observed in HIV-1 Infection , 2002, The Journal of Immunology.
[18] W. Greene,et al. HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis. , 2002, Virology.
[19] J. Kim,et al. The HIV-1 accessory gene vpr can inhibit antigen-specific immune function. , 2002, DNA and cell biology.
[20] R. Steinman,et al. Exploiting dendritic cells to improve vaccine efficacy. , 2002, The Journal of clinical investigation.
[21] M. Pope,et al. The enigma of dendritic cell-immunodeficiency virus interplay. , 2002, Current molecular medicine.
[22] B. Gazzard,et al. Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection , 2002, AIDS.
[23] Michael Loran Dustin. Membrane domains and the immunological synapse: keeping T cells resting and ready. , 2002, The Journal of clinical investigation.
[24] S. Moretti,et al. Native HIV-1 Tat Protein Targets Monocyte-Derived Dendritic Cells and Enhances Their Maturation, Function, and Antigen-Specific T Cell Responses1 , 2002, The Journal of Immunology.
[25] D. Weiner,et al. HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro. , 2001, Virology.
[26] Antonio Lanzavecchia,et al. Regulation of T Cell Immunity by Dendritic Cells , 2001, Cell.
[27] J. Mellors,et al. Restoration of Anti-Human Immunodeficiency Virus Type 1 (HIV-1) Responses in CD8+ T Cells from Late-Stage Patients on Prolonged Antiretroviral Therapy by Stimulation In Vitro with HIV-1 Protein-Loaded Dendritic Cells , 2001, Journal of Virology.
[28] Yonghong Zhu,et al. Comparison of Cell Cycle Arrest, Transactivation, and Apoptosis Induced by the Simian Immunodeficiency Virus SIVagm and Human Immunodeficiency Virus Type 1 vpr Genes , 2001, Journal of Virology.
[29] J. Orenstein,et al. Low levels of productive HIV infection in Langerhans cell‐like dendritic cells differentiated in the presence of TGF‐β1 and increased viral replication with CD40 ligand‐induced maturation , 2001, European journal of immunology.
[30] F. Sallusto,et al. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells , 2000, Nature Immunology.
[31] P. Matarrese,et al. Dual Role of the HIV-1 Vpr Protein in the Modulation of the Apoptotic Response of T Cells1 , 2000, The Journal of Immunology.
[32] L. Montaner,et al. Proinflammatory response and IL‐12 expression in HIV‐1 infection , 2000, Journal of leukocyte biology.
[33] B. Wigdahl,et al. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. , 2000, Virology.
[34] A. Alcamí,et al. Viral mechanisms of immune evasion , 2000, Immunology Today.
[35] K. Kuhen,et al. Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. , 2000, Blood.
[36] J. Hauber,et al. Mature Dendritic Cells Infected with Herpes Simplex Virus Type 1 Exhibit Inhibited T-Cell Stimulatory Capacity , 2000, Journal of Virology.
[37] Christopher J. Miller,et al. Simian Immunodeficiency Virus Rapidly Penetrates the Cervicovaginal Mucosa after Intravaginal Inoculation and Infects Intraepithelial Dendritic Cells , 2000, Journal of Virology.
[38] M. Lederman,et al. Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen , 2000, AIDS.
[39] D. Richman,et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. , 1999, Science.
[40] I. Chen,et al. Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[41] R. Steinman,et al. Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. , 1999, Science.
[42] M. Foti,et al. Coordinated events during bacteria-induced DC maturation. , 1999, Immunology today.
[43] D. Baltimore,et al. HIV's evasion of the cellular immune response , 1999, Immunological reviews.
[44] G. Chrousos,et al. The HIV-1 Virion-associated Protein Vpr Is a Coactivator of the Human Glucocorticoid Receptor , 1999, The Journal of experimental medicine.
[45] I. Chen,et al. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. , 1998, Science.
[46] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[47] B. Walker,et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.
[48] J. Banchereau,et al. Measles Virus Infects Human Dendritic Cells and Blocks Their Allostimulatory Properties for CD4+ T Cells , 1997, The Journal of experimental medicine.
[49] M. Bevan,et al. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. , 1997, Blood.
[50] S. Bartz,et al. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. , 1997, Methods.
[51] M. Clerici,et al. Type 1 and type 2 cytokines in HIV infection -- a possible role in apoptosis and disease progression. , 1997, Annals of medicine.
[52] R. Steinman,et al. Efficient Interaction of HIV-1 with Purified Dendritic Cells via Multiple Chemokine Coreceptors , 1996, The Journal of experimental medicine.
[53] N. Saksena,et al. Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma. , 1996, Virology.
[54] A. Lanzavecchia,et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.
[55] A I Spira,et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques , 1996, The Journal of experimental medicine.
[56] O. Narayan,et al. Interaction of Virion Protein Vpr of Human Immunodeficiency Virus Type 1 with Cellular Transcription Factor Sp1 and trans-Activation of Viral Long Terminal Repeat (*) , 1995, The Journal of Biological Chemistry.
[57] F. Sallusto,et al. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.
[58] J. Sodroski,et al. Human immunodeficiency virus vpr product is a virion-associated regulatory protein , 1990, Journal of virology.
[59] A. Frankel,et al. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. , 1989, Science.
[60] K. Khalili,et al. Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[61] J. Abastado,et al. HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. , 2002, Immunity.
[62] J. Kim,et al. HIV-1 viral protein R compromises cellular immune function in vivo. , 2002, International immunology.
[63] H. Ploegh,et al. Viral subversion of the immune system. , 2000, Annual review of immunology.
[64] M. Bukrinsky,et al. Viral protein R of HIV‐1 , 1999, Reviews in medical virology.
[65] D. Ho,et al. Cellular targets of infection and route of viral dissemination following an intravaginal inoculation of SIV into rhesus macaques , 1998 .
[66] D. Green,et al. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. , 1997, Nature medicine.
[67] A. Osterhaus,et al. Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion. , 1990, AIDS.
[68] B. Watkins,et al. Understanding HIV-1 infection of the brain: a challenge for neurobiologists. , 1990, AIDS.